Are we closer to a new strategy in the treatment of cardiac arrest?

Resuscitation

Volumn 80, Issue 6, 2009, Pages 613-614

  Pytte, Morten ^a   Steen, Petter A ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cardiac arrest; Drug therapy; Outcome

Indexed keywords

CYTOKINE; ENDOTOXIN; ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PLACEBO; REACTIVE OXYGEN METABOLITE; RECOMBINANT ERYTHROPOIETIN;

APOPTOSIS; BRAIN DAMAGE; CELL DEATH; EDITORIAL; HEART ARREST; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HOSPITAL DISCHARGE; HUMAN; INDUCED HYPOTHERMIA; INTENSIVE CARE UNIT; NECROSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; RESUSCITATION;

CARDIOPULMONARY RESUSCITATION; CARDIOVASCULAR AGENTS; ERYTHROPOIETIN; HEART ARREST; HUMANS;

EID: 67349132874     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2009.04.001     Document Type: Editorial

References (21)

1. Nolan J.P., Neumar R.W., Adrie C., et al. Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation 79 (2008) 350-379
2. Adrie C., Adib-Conquy M., Laurent I., et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 106 (2002) 562-568
3. Tang W., Weil M.H., Sun S., et al. KATP channel activation reduces the severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 279 (2000) H1609
4. Bernard S.A., Gray T.W., Buist M.D., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346 (2002) 557-563
5. Forsman M., Fleischer J.E., Milde J.H., et al. Superoxide dismutase and catalase failed to improve neurologic outcome after complete cerebral ischemia in the dog. Acta Anaesthesiol Scand 32 (1988) 152-155
6. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. Brain Resuscitation Clinical Trial II Study Group. N Engl J Med 1991;324:1225-31.
7. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61 (2004) 448-460
8. Cai Z., and Semenza G.L. Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109 (2004) 2050-2053
9. Moon C., Krawczyk M., Ahn D., et al. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA 100 (2003) 11612-11617
10. Hirata A., Minamino T., Asanuma H., et al. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts. Cardiovasc Drugs Ther 19 (2005) 33-40
11. Morishita E., Masuda S., Nagao M., et al. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76 (1997) 105-116
12. Sirén A.L., Fratelli M., Brines M., et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci USA 98 (2001) 4044-4049
13. Ehrenreich H., Hasselblatt M., Dembowski C., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8 (2002) 495-505
14. Singh D., Kolarova J.D., Wang S., et al. Myocardial protection by erythropoietin during resuscitation from ventricular fibrillation. Am J Ther 14 (2007) 361-368
15. Huang C.H., Hsu C.Y., Chen H.W., et al. Erythropoietin improves the postresuscitation myocardial dysfunction and survival in the asphyxia-induced cardiac arrest model. Shock 28 (2007) 53-58
16. Popp E., Vogel P., Teschendorf P., et al. Effects of the application of erythropoietin on cerebral recovery after cardiac arrest in rats. Resuscitation 74 (2007) 344-351
17. Cariou A., Claessens Y.E., Pène F., et al. Early high-dose erythropoietin therapy and hypothermia after out-of-hospital cardiac arrest: a matched control study. Resuscitation 76 (2008) 397-404
18. Grmec S., Strnad M., Kupnik D., et al. Erythropoietin facilitates the return of spontaneous circulation and survival in victims of out-of-hospital cardiac arrest. Resuscitation 80 (2009) 631-637
19. Kramer-Johansen J., Edelson D.P., Losert H., et al. Uniform reporting of measured quality of cardiopulmonary resuscitation (CPR). Resuscitation 74 (2007) 406-417
20. Wenzel V., Krismer A.C., Arntz H.R., et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350 (2004) 105-113
21. Böttiger B.W., Arntz H., Chamberlain D.A., et al. Thrombolysis during resuscitation for out-of-hospital cardiac arrest. N Engl J Med 359 (2008) 2651-2662